LEADER 02760nam  2200385z- 450 
001 9910346842603321
005 20240424225706.0
010   $a3-03897-635-0
035   $a(CKB)4920000000095214
035   $a(oapen)https://directory.doabooks.org/handle/20.500.12854/45007
035   $a(EXLCZ)994920000000095214
100   $a20202102d2019      |y         0
101 0 $aeng
135   $aurmn|---annan
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aDiagnostic, prognostic and predictive biological markers in bladder cancer $eillumination of a vision /$fspecial issue editors, Thorsten Ecke, Thomas Otto
210   $cMDPI - Multidisciplinary Digital Publishing Institute$d2019
215   $a1 electronic resource (202 p.)
311   $a3-03897-634-2 
330   $aThis Special Issue has been introduced with the aim of offering the possibility to publish new research results from old and new pioneers in the field of bladder cancer basic research. While editing this Special Issue we learned that an enormous enthusiasm is necessary to go on in bladder cancer research. In our eyes, bladder cancer is on one hand a very heterogenous malignancy, which is what makes it so difficult to focus on only one bladder cancer marker in bladder cancer diagnostics and follow-up. On the other hand, it is very important to find prognostic and predictive factors for bladder cancer due to its high incidence and its enormous costs, as one of the most expensive malignancies in the world. Finding and developing new bladder cancer markers is still a very dynamic field. Because there are many of these markers, it is impossible to report all of them. This Special Issue attempts to highlight the role of bladder cancer markers in diagnosis, and the most important biomarkers that have been recently studied and reported. This Special Issue highlights some of the most important markers. Further determination of recurrence and progression markers will contribute to establishing better treatments for individual patients. Molecular staging of urological tumors will allow the selection of cases that will require systemic treatment. It is necessary and important to integrate basic and clinical research under the same objectives.
606   $aBladder$xCancer$xDiagnosis
610   $amolecular biology
610   $adiagnostics
610   $atumor markers
610   $aBladder cancer
615  0$aBladder$xCancer$xDiagnosis.
676   $a616.99/462
702   $aEcke$b Thorsten Holger$f1972-
702   $aOtto$b Thomas$cProf. Dr.,
906   $aBOOK
912   $a9910346842603321
996   $aDiagnostic, prognostic and predictive biological markers in bladder cancer$93401072
997   $aUNINA